Tech Company Financing Transactions
Axio BioPharma Funding Round
Axio BioPharma, based in Madison, raised $2.4 million in investment from Chemical Angel Network and private investors.
Transaction Overview
Company Name
Announced On
9/25/2026
Transaction Type
Venture Equity
Amount
$2,400,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to support initial deployments of Axio Lattice and the continued development of Rosetta, its ontology mapping layer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
504 S. Rosa Rd. 200
Madison, WI 53719
USA
Madison, WI 53719
USA
Phone
Website
Email Address
Overview
Axio BioPharma began with Forge: a biologics lab built around the belief that AI could meaningfully change how bioprocess development works. Built in a lab. Building for the industry. Forge is our foundation. A lab where real work, real data, and real constraints shaped our perspective. Bioprocess teams don't lack data. They lack connected, usable context. Biologics development generates valuable knowledge, but that knowledge breaks down as it moves across systems, teams, and organizations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Justin Byers
Chief Technical Officer
Brian Staats
Browse more venture capital transactions:
Prev: 9/24/2026: United Immunity venture capital transaction
Next: 9/25/2026: Nauticus Robotics venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs